AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Oct. 16, 2026

Cronos Group Inc. CRON Stock Forecast

AI-powered price prediction and analysis for Cronos Group Inc. · Alpha · vs marketSwitch to Total

Follow
AI 90-Day Forecast HOLD Alpha
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence -21.0% Spearman Correlation (n=357) · 30D -15.0%

See CRON's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

CRON
Fundamentals

Key Statistics

Market Cap$1.18B
P/E Ratio18.9x
P/B Ratio1.11x
EPS$0.17
ROE6.6%
Net Margin29.6%
Revenue$237M
Current Ratio16.18x
D/E Ratio0.06x
Company

About Cronos Group Inc.

Cronos Group Inc. (CRON) operates within the Life Sciences sector, specifically in the Medicinal Chemicals & Botanical Products industry.

Life Sciences Medicinal Chemicals & Botanical Products Nasdaq Small Cap
News

Latest News

  • Loading...

Where CRON sits on the market map

Life Sciences · Medicinal Chemicals & Botanical Products
Explore the map →
Industry Peers

Medicinal Chemicals & Botanical Products Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
CRON Cronos Group Inc. ▶ $1.18B 18.9x
DFTX Definium Therapeutics, Inc. ▲ $4.31B –
TRLV Trulieve Cannabis Corp. ▲ $1.93B –
TLRY Tilray Brands, Inc. ▼ $414M –
SNDL Sndl Inc. ▶ $322M –
CGC Canopy Growth Corp ▶ $302M –
GLAS Glass House Brands Inc. ▼ $301M –
USNA Usana Health Sciences Inc ▼ $287M –
ACB Aurora Cannabis Inc ▶ $253M –
NAGE Niagen Bioscience, Inc. ▶ $197M 14.7x
MDWD Mediwound Ltd. ▶ $152M –
AAWH Ascend Wellness Holdings, Inc. ▲ $80M –
FTLF Fitlife Brands, Inc. ▲ $79M 12.9x
BTMD Biote Corp. ▲ $35M 2.7x
RAPH Raphael Pharmaceutical Inc. ▼ $30M 25.2x
CHUC Charlie's Holdings, Inc. ▼ $27M –
MRMD Marimed Inc. ▲ $24M –
CFOO China Foods Holdings Ltd. ▼ $21M –
MTEX Mannatech Inc ▲ $14M 5.8x
ADIA Adia Med, Inc. ▲ $13M –
GLUC Glucose Health, Inc. ▼ $9M –
NAII Natural Alternatives International Inc ▲ $7M –
BON Bon Natural Life Ltd ▶ $7M –
PLSH Panacea Life Sciences Holdings, … ▲ $6M –
CYAN Cyanotech Corp ▲ $5M –
IMCC Im Cannabis Corp. ▼ $2M –
AIBT Aibotics, Inc. ▼ $2M –
NPHC Nutra Pharma Corp ▼ $720K –
MEHA Functional Brands Inc. ▼ $290K –
CBDY Target Group Inc. ▼ N/A –
HYEX Healthy Extracts Inc. ▶ N/A –
NTRR Neutra Corp. ▼ N/A –
SNYRQ Synergy Chc Corp. ▼ N/A –
FAQ

FAQ

Is Cronos Group Inc. a good stock to buy?

Our AI analyzes Cronos Group Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are Cronos Group Inc. predictions?

For CRON, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -21.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -15.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

Cronos Group Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of Cronos Group Inc.? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.